Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2000218rdf:typepubmed:Citationlld:pubmed
pubmed-article:2000218lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2000218lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:2000218lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:2000218lifeskim:mentionsumls-concept:C1333600lld:lifeskim
pubmed-article:2000218lifeskim:mentionsumls-concept:C0039082lld:lifeskim
pubmed-article:2000218lifeskim:mentionsumls-concept:C2826170lld:lifeskim
pubmed-article:2000218pubmed:issue2lld:pubmed
pubmed-article:2000218pubmed:dateCreated1991-4-9lld:pubmed
pubmed-article:2000218pubmed:abstractTextImmortal cell lines arose spontaneously during in vitro culture of initially normal fibroblasts, MDAH041 and MDAH087, from patients with Li-Fraumeni familial cancer syndrome. Fibroblasts from a control donor, MDAH170, maintained a normal morphology and senesced at 31 population doublings. The immortal fibroblasts have several properties of transformed cells. In addition to having acquired an altered morphology and chromosomal anomalies, MDAH041 and MDAH087 have escaped from senescence, growing beyond 300 and 100 population doublings (pd), respectively. As early as 50 pd, these cells can be transformed by an activated H-ras oncogene to form tumors in nude mice. However, MDAH041 immortal cells were resistant to tumorigenic transformation by transfection with the v-abl oncogene.lld:pubmed
pubmed-article:2000218pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2000218pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2000218pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2000218pubmed:languageenglld:pubmed
pubmed-article:2000218pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2000218pubmed:citationSubsetIMlld:pubmed
pubmed-article:2000218pubmed:statusMEDLINElld:pubmed
pubmed-article:2000218pubmed:monthFeblld:pubmed
pubmed-article:2000218pubmed:issn0950-9232lld:pubmed
pubmed-article:2000218pubmed:authorpubmed-author:GiovanellaB...lld:pubmed
pubmed-article:2000218pubmed:authorpubmed-author:TainskyM AMAlld:pubmed
pubmed-article:2000218pubmed:authorpubmed-author:SicilianoM...lld:pubmed
pubmed-article:2000218pubmed:authorpubmed-author:StrongL CLClld:pubmed
pubmed-article:2000218pubmed:authorpubmed-author:YimS OSOlld:pubmed
pubmed-article:2000218pubmed:authorpubmed-author:BischoffF ZFZlld:pubmed
pubmed-article:2000218pubmed:authorpubmed-author:PrattD RDRlld:pubmed
pubmed-article:2000218pubmed:issnTypePrintlld:pubmed
pubmed-article:2000218pubmed:volume6lld:pubmed
pubmed-article:2000218pubmed:geneSymbolv-abllld:pubmed
pubmed-article:2000218pubmed:geneSymbolH-raslld:pubmed
pubmed-article:2000218pubmed:ownerNLMlld:pubmed
pubmed-article:2000218pubmed:authorsCompleteYlld:pubmed
pubmed-article:2000218pubmed:pagination183-6lld:pubmed
pubmed-article:2000218pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:meshHeadingpubmed-meshheading:2000218-...lld:pubmed
pubmed-article:2000218pubmed:year1991lld:pubmed
pubmed-article:2000218pubmed:articleTitleTumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome.lld:pubmed
pubmed-article:2000218pubmed:affiliationDepartment of Tumor Biology, University of Texas, M.D. Anderson Cancer Center, Houston 77030.lld:pubmed
pubmed-article:2000218pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2000218pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2000218pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2000218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2000218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2000218lld:pubmed